Jounce Therapeutics ( JNCE) is about to get crushed thanks to an updateto its ICONIC study, in which, 46 patients were enrolled into six cohorts to study its leading drug candidate, JTX-2011. This drug is being tested for anti-tumor and anti-cancer activity. Let us discuss what is going on here.
E Buy Jounce For A Bounce
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться